185 related articles for article (PubMed ID: 9550390)
1. Role for IL-15/IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development.
Ohteki T; Ho S; Suzuki H; Mak TW; Ohashi PS
J Immunol; 1997 Dec; 159(12):5931-5. PubMed ID: 9550390
[TBL] [Abstract][Full Text] [Related]
2. Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production.
Beutner U; Launois P; Ohteki T; Louis JA; MacDonald HR
Eur J Immunol; 1997 Apr; 27(4):928-34. PubMed ID: 9130646
[TBL] [Abstract][Full Text] [Related]
3. Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen.
Schulz RJ; Parkes A; Mizoguchi E; Bhan AK; Koyasu S
J Immunol; 1996 Nov; 157(10):4379-89. PubMed ID: 8906813
[TBL] [Abstract][Full Text] [Related]
4. Mouse gamma delta TCR+NK1.1+ thymocytes specifically produce interleukin-4, are major histocompatibility complex class I independent, and are developmentally related to alpha beta TCR+NK1.1+ thymocytes.
Vicari AP; Mocci S; Openshaw P; O'Garra A; Zlotnik A
Eur J Immunol; 1996 Jul; 26(7):1424-9. PubMed ID: 8766542
[TBL] [Abstract][Full Text] [Related]
5. Identification and cellular distribution of the rat interleukin-2 receptor beta chain: induction of the IL-2R alpha- beta+ phenotype by major histocompatibility complex class I recognition during T cell development in vivo and by T cell receptor stimulation of CD4+8+ immature thymocytes in vitro.
Park JH; Hanke T; Hünig T
Eur J Immunol; 1996 Oct; 26(10):2371-5. PubMed ID: 8898947
[TBL] [Abstract][Full Text] [Related]
6. Involvement of NK1+ CD4- CD8- alphabeta T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice.
Nakamura E; Kubota H; Sato M; Sugie T; Yoshida O; Minato N
J Immunol; 1997 Jun; 158(11):5338-48. PubMed ID: 9164954
[TBL] [Abstract][Full Text] [Related]
7. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
[TBL] [Abstract][Full Text] [Related]
8. Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation.
Moodycliffe AM; Maiti S; Ullrich SE
J Immunol; 1999 May; 162(9):5156-63. PubMed ID: 10227987
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12.
Hashimoto W; Takeda K; Anzai R; Ogasawara K; Sakihara H; Sugiura K; Seki S; Kumagai K
J Immunol; 1995 May; 154(9):4333-40. PubMed ID: 7722291
[TBL] [Abstract][Full Text] [Related]
10. Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis.
Takeda K; Seki S; Ogasawara K; Anzai R; Hashimoto W; Sugiura K; Takahashi M; Satoh M; Kumagai K
J Immunol; 1996 May; 156(9):3366-73. PubMed ID: 8617962
[TBL] [Abstract][Full Text] [Related]
11. IL-4-producing NK1.1+ T cells are resistant to glucocorticoid-induced apoptosis: implications for the Th1/Th2 balance.
Tamada K; Harada M; Abe K; Li T; Nomoto K
J Immunol; 1998 Aug; 161(3):1239-47. PubMed ID: 9686584
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine-activated killer cells. VII. IL-4 induces an NK1.1+CD8 alpha+beta- TCR-alpha beta B220+ lymphokine-activated killer subset.
Ballas ZK; Rasmussen W
J Immunol; 1993 Jan; 150(1):17-30. PubMed ID: 7678028
[TBL] [Abstract][Full Text] [Related]
13. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
[TBL] [Abstract][Full Text] [Related]
14. Characterization and function of the NKR-P1dim/T cell receptor-alpha beta+ subset of rat T cells.
Brissette-Storkus C; Kaufman CL; Pasewicz L; Worsey HM; Lakomy R; Ildstad ST; Chambers WH
J Immunol; 1994 Jan; 152(2):388-96. PubMed ID: 7506720
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4-producing CD4+ NK1.1+ TCR alpha/beta intermediate liver lymphocytes are down-regulated by Listeria monocytogenes.
Emoto M; Emoto Y; Kaufmann SH
Eur J Immunol; 1995 Dec; 25(12):3321-5. PubMed ID: 8566018
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: evidence that liver NK1.1+TCR alpha beta+ cells originate from multiple pathways.
Ohteki T; Maki C; Koyasu S; Mak TW; Ohashi PS
J Immunol; 1999 Apr; 162(7):3753-6. PubMed ID: 10201888
[TBL] [Abstract][Full Text] [Related]
17. TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation.
Prussin C; Foster B
J Immunol; 1997 Dec; 159(12):5862-70. PubMed ID: 9550382
[TBL] [Abstract][Full Text] [Related]
18. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth.
Chastagner P; Moreau JL; Jacques Y; Tanaka T; Miyasaka M; Kondo M; Sugamura K; Thèze J
Eur J Immunol; 1996 Jan; 26(1):201-6. PubMed ID: 8566067
[TBL] [Abstract][Full Text] [Related]
19. TCR alpha beta+ anti-tumor cytolytic T lymphocytes express NKR-P1 whilethe anti-tumor activity of TCR gamma delta+ T lymphocytes is not correlated to NKR-P1 expression.
Yrlid U; Petersson E; Dohlsten M; Hedlund G
Cell Immunol; 1996 Nov; 173(2):287-94. PubMed ID: 8912889
[TBL] [Abstract][Full Text] [Related]
20. MHC class II-dependent NK1.1+ gammadelta T cells are induced in mice by Salmonella infection.
Nishimura H; Washizu J; Naiki Y; Hara T; Fukui Y; Sasazuki T; Yoshikai Y
J Immunol; 1999 Feb; 162(3):1573-81. PubMed ID: 9973415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
